Chongqing International Inspection Medicine, Blood Transfusion Reagent Exhibition and so on you come to the exhibition, round you will show your dream, because of the uncontrollable nature of the exhibition, there may be a change of theme, delay or cancellation of the situation, before the exhibition visit please contact the organizers to verify! Follow the convention number to learn about the event.
In recent years, new technologies and models have emerged in the global in vitro diagnostic industry, with molecular diagnostic technology represented by second-generation gene sequencing (NGS), instant detection products represented by microfloronic control chips, and new technologies and new technologies such as modern health management and precision medicine represented by big data, "Internet Plus" and new models opening up new growth space for in vitro diagnostics. With the continuous upgrading of in vitro diagnostic technology and the wide application of related cutting-edge science and technology, the global in vitro diagnostic market will continue to grow. In addition, after the outbreak of new coronary pneumonia, how to quickly and accurately screen and confirm patients with new coronary pneumonia has become the top priority of epidemic prevention and control. In the rapid development of various new technologies and the new coronary pneumonia epidemic catalyzed environment, in vitro diagnosis (IVD) industry will be rapid development, the future is expected to become the medical device industry development of one of the active and fast market. Chongqing International Inspection Medicine and In vitro Diagnostic Reagents Exhibition after years of accumulation and precipitation, has now developed into an international leading coverage of the whole industry chain of inspection medicine, set product technology, new product launch, procurement trade, brand communication, scientific research cooperation, academic forums, education and training as one of the integrated global service platform. The exhibition covers tens of thousands of products and services in the entire industrial chain, such as IVD reagents, analytical instruments, auxiliary equipment and consumables, precision medicine, reagent raw materials, etc.
2025年
展會時間：待定
展會地點：待定
2026年
展會時間：待定
展會地點：待定
2027年
展會時間：待定
展會地點：待定
近年來，全球體外診斷行業(yè)新技術(shù)、新模式不斷出現(xiàn)，以二代基因測序（NGS）為代表的分子診斷技術(shù)、以微流控芯片為代表的即時檢測產(chǎn)品，以及以大數(shù)據(jù)、“互聯(lián)網(wǎng)+”為代表的現(xiàn)代健康管理和精準(zhǔn)醫(yī)療等新技術(shù)、新模式為體外診斷行業(yè)打開了新的成長空間。伴隨著體外診斷技術(shù)的不斷升級和相關(guān)前沿科學(xué)技術(shù)的廣泛應(yīng)用，全球體外診斷市場規(guī)模將保持持續(xù)增長態(tài)勢。另外，新冠肺炎疫情發(fā)生后，如何快速、準(zhǔn)確篩查并確診新冠肺炎患者成為疫情防控的重中之重。在各種新技術(shù)迅速發(fā)展及新冠肺炎疫情催化的大環(huán)境下，體外診斷（IVD）行業(yè)將得到快速發(fā)展，未來有望成為醫(yī)療器械行業(yè)發(fā)展**活躍且**快的市場之一。
重慶國際檢驗醫(yī)學(xué)及體外診斷試劑展覽會歷經(jīng)多年的積累和沉淀，現(xiàn)已發(fā)展成為國際領(lǐng)先的覆蓋檢驗醫(yī)學(xué)全產(chǎn)業(yè)鏈、集產(chǎn)品技術(shù)、新品首發(fā)、采購貿(mào)易、品牌傳播、科研合作、學(xué)術(shù)論壇、教育培訓(xùn)為一體的全球化綜合服務(wù)平臺。展出內(nèi)容涵蓋了IVD試劑、分析儀器、輔助設(shè)備及耗材、精準(zhǔn)醫(yī)療、試劑原料等全產(chǎn)業(yè)鏈上的數(shù)萬種產(chǎn)品技術(shù)與服務(wù)。
參展范圍
血液分析系統(tǒng)：血型分析儀、血型卡、全自動細胞分析儀、全自動涂卡機、血流變儀、半自動血細胞分析儀、半自動血栓、血凝分析儀自動血庫系統(tǒng)、血紅蛋白測定儀、血小板聚集儀、血糖分析儀血液粘度計、血栓彈力儀、紅細胞變形儀、血液流變參數(shù)測試儀流式細胞分析儀、全自動血栓止血分析系統(tǒng)、全自動凝血纖溶分析儀等；
生化分析系統(tǒng)：全自動生化分析儀、全自動快速（干式）生化分析儀、半自動生化分析儀、全自動多項電解質(zhì)分析儀、半自動單/多項電解質(zhì)分析儀等；
免疫分析系統(tǒng)：全自動免疫分析儀、半自動酶標(biāo)儀、熒光顯微檢測系統(tǒng)、特定蛋白分析儀、化學(xué)發(fā)光測定儀、熒光免疫分析儀、流式點陣儀、酶免儀等；
細菌分析系統(tǒng)：結(jié)核桿菌分析儀、藥敏分析儀、細菌測定系統(tǒng)、快速細菌培養(yǎng)儀、幽門螺旋桿菌測定儀等；
尿液分析系統(tǒng)：自動尿液分析儀及試紙等；
生物分離系統(tǒng)：全自動電泳儀、毛細管電泳儀、等電聚焦電泳儀、核酸提純分析儀、低中高壓電泳儀、細胞電泳儀、全自動血氣分析儀、組織氧含量測定儀、經(jīng)皮血氧分壓監(jiān)測儀、血氣采血器、血氧飽和度測定儀、CO₂紅外分析儀、血氣酸堿分析儀、電化學(xué)測氧儀等；
基因和生命科學(xué)儀器：全自動醫(yī)用PCR分析系統(tǒng)、精子分析儀、PCR擴增儀、生物芯片閱讀儀等；
臨床醫(yī)學(xué)檢驗輔助設(shè)備：超凈裝置、血球計數(shù)板、自動加樣系統(tǒng)、自動進樣系統(tǒng)、血型儀、洗板機等；
實驗器具類：耗材、醫(yī)用冰箱、輸血器具、顯微器材、電子天平、試驗臺具；
試劑：診斷試劑、通用試劑、基準(zhǔn)試劑、分析試劑、儀器分析試劑、臨床化學(xué)試劑、輸血試劑、酶免分析免疫試劑、基因檢測、微生物學(xué)檢驗等；
上游原材料：抗原和抗體、酶/輔酶/酶底物、磁微粒/微球/NC膜等。
Chongqing International Inspection Medicine, Blood Transfusion Reagent Exhibition and so on you come to the exhibition, round you will show your dream, because of the uncontrollable nature of the exhibition, there may be a change of theme, delay or cancellation of the situation, before the exhibition visit please contact the organizers to verify! Follow the convention number to learn about the event.
In recent years, new technologies and models have emerged in the global in vitro diagnostic industry, with molecular diagnostic technology represented by second-generation gene sequencing (NGS), instant detection products represented by microfloronic control chips, and new technologies and new technologies such as modern health management and precision medicine represented by big data, "Internet Plus" and new models opening up new growth space for in vitro diagnostics. With the continuous upgrading of in vitro diagnostic technology and the wide application of related cutting-edge science and technology, the global in vitro diagnostic market will continue to grow. In addition, after the outbreak of new coronary pneumonia, how to quickly and accurately screen and confirm patients with new coronary pneumonia has become the top priority of epidemic prevention and control. In the rapid development of various new technologies and the new coronary pneumonia epidemic catalyzed environment, in vitro diagnosis (IVD) industry will be rapid development, the future is expected to become the medical device industry development of one of the active and fast market.
Chongqing International Inspection Medicine and In vitro Diagnostic Reagents Exhibition after years of accumulation and precipitation, has now developed into an international leading coverage of the whole industry chain of inspection medicine, set product technology, new product launch, procurement trade, brand communication, scientific research cooperation, academic forums, education and training as one of the integrated global service platform. The exhibition covers tens of thousands of products and services in the entire industrial chain, such as IVD reagents, analytical instruments, auxiliary equipment and consumables, precision medicine, reagent raw materials, etc.